Advertisement
Screener

MAIA Biotechnology, Inc. (MAIA) Form D

MAIA Biotechnology, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2026-01-05: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-12-22; Total offering amount $2,000,000.
  • 2025-10-14: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-09-29; Total offering amount $7,000,000.
  • 2025-06-11: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-05-28; Total offering amount $8,000,000.
  • 2025-03-04: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-02-18; Total offering amount $5,895,225.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2026-01-05Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-12-22$2,000,000$1,509,789$490,21117
2025-10-14Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-09-29$7,000,000$2,990,496$4,009,50417
2025-06-11Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-05-28$8,000,000$694,998$7,305,00211
2025-03-04Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-02-18$5,895,225$4,143,949$1,751,27643
2024-11-12Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-10-28$15,500,000$2,439,260$13,060,74021
2024-03-21Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-03-11$5,700,000$2,920,692$2,779,30819
2023-11-29Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2023-11-15$4,859,092$4,859,092$03

Similar stocks

Stock NameCountryMarket CapPE Ratio
iBio, Inc. (IBIO)United States$0.077B-2.94
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41